Pallister-Killian syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:884OMIM:601803Q99.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pallister-Killian syndrome (PKS), also known as tetrasomy 12p mosaicism or isochromosome 12p syndrome, is a rare chromosomal disorder caused by the presence of an extra isochromosome composed of two copies of the short arm of chromosome 12 (i(12p)). This supernumerary isochromosome is typically present in a mosaic pattern, meaning it is found in some cells but not others. The condition is not inherited but arises as a sporadic event during cell division, most often during maternal meiosis. Because the abnormal chromosome is preferentially lost from blood lymphocytes, diagnosis often requires analysis of skin fibroblasts or buccal mucosal cells rather than standard blood karyotyping, though chromosomal microarray on blood can detect the gain of 12p material. PKS affects multiple body systems. Key clinical features include characteristic facial features (high forehead, sparse anterior scalp hair in infancy, broad flat nasal bridge, wide mouth with a thin upper lip, and a long philtrum), profound to severe intellectual disability, seizures (often infantile spasms), hypotonia (markedly reduced muscle tone from birth), and streaks of skin hypopigmentation or hyperpigmentation following the lines of Blaschko. Congenital anomalies are common and may include diaphragmatic hernia, congenital heart defects, renal anomalies, and supernumerary nipples. Many affected individuals have limited or absent speech development and significant motor delays. Hearing loss and vision problems may also occur. There is no cure for Pallister-Killian syndrome, and management is supportive and multidisciplinary. Treatment focuses on addressing individual symptoms: antiepileptic medications for seizures, physical and occupational therapy for motor delays, speech therapy, and surgical correction of congenital anomalies such as diaphragmatic hernia or cardiac defects when needed. Early intervention programs are recommended to optimize developmental outcomes. Life expectancy is variable; some individuals with severe congenital malformations may have a shortened lifespan, while others survive into adulthood with significant support needs.

Also known as:

Clinical phenotype terms— hover any for plain English:

Thick upper lip vermilionHP:0000215
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pallister-Killian syndrome.

View clinical trials →

No actively recruiting trials found for Pallister-Killian syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pallister-Killian syndrome community →

No specialists are currently listed for Pallister-Killian syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pallister-Killian syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pallister-Killian syndromeForum →

No community posts yet. Be the first to share your experience with Pallister-Killian syndrome.

Start the conversation →

Latest news about Pallister-Killian syndrome

No recent news articles for Pallister-Killian syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pallister-Killian syndrome

What is Pallister-Killian syndrome?

Pallister-Killian syndrome (PKS), also known as tetrasomy 12p mosaicism or isochromosome 12p syndrome, is a rare chromosomal disorder caused by the presence of an extra isochromosome composed of two copies of the short arm of chromosome 12 (i(12p)). This supernumerary isochromosome is typically present in a mosaic pattern, meaning it is found in some cells but not others. The condition is not inherited but arises as a sporadic event during cell division, most often during maternal meiosis. Because the abnormal chromosome is preferentially lost from blood lymphocytes, diagnosis often requires a

How is Pallister-Killian syndrome inherited?

Pallister-Killian syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pallister-Killian syndrome typically begin?

Typical onset of Pallister-Killian syndrome is neonatal. Age of onset can vary across affected individuals.